Autoantibodies and common viral illnesses

doi:10.1016/S0049-0172(98)80047-4

Seminars in Arthritis and Rheumatism

Volume 27, Issue 5, April 1998, Pages 263-271

https://doi.org/10.1016/S0049-0172(98)80047-4 Get rights and content

Abstract

Objectives:

To review the literature about common autoantibodies produced in association with viral infection.

Methods:

Medline review of the medical literature published in English.

Results:

Common viral infections are often associated with low-titer, polyspecific autoantibodies. However, high-titer antinuclear antibodies, double-stranded DNA antibodies, anticardiolipin antibodies, and other subtype antibodies may be found. Hepatitis C and B virus, human immunodeficiency virus, and parvovirus B19 appear to be associated with autoantibodies more commonly than other viruses.

Conclusions:

Transient autoantibodies resulting from viral infections are notuncommon. Clinical and laboratory follow-up over time will help distinguish between connective tissue disease and self-limited illness.

References (39)

SchattnerA.
The origin of autoantibodies
Immunol Lett
(1987)
VaaralaO. et al.
Anticardiolipin response in acute infection
Clin Immunol Immunopathol
(1986)
ColacoC.B. et al.
Anticardiolipin antibodies in viral infection
Lancet
(1989)
SchooleyR.T. et al.
Antineutrophil antibodies in infectious mononucleosis
Am J Med
(1984)
SeigneurinJ.M. et al.
Polyspecific natural antibodies and autoantibodies secreted by human lymphocytes immortalized with Epstein-Barr virus
Blood
(1988)
LuzziG.A. et al.
Human parvovirus arthropathy and rheumatoid factor
Lancet
(1985)
KerrJ.R. et al.
Autoantibodies following parvovirus B19 injection
J Infect
(1996)
CliffordB. et al.
High prevalence of serological markers of autoimmunity in patient with chronic hepatitis C
Hepatology
(1995)
McMurrayR.W. et al.
Hepatitis C virus infection and autoimmunity
Semin Arthritis Rheum
(1997)
GregorioG.V. et al.
Autoantibody prevalence in chronic hepatitis B virus infection: Effect in interferon-alfa
Hepatology
(1996)

GutierrezA. et al.

Transient positivity of antinuclear and antismooth muscle antibodies in hepatitis A virus infection

J Hepatol

(1996)

DorsettB. et al.

Antilymphocyte antibodies in patients with the acquired immunodeficiency syndrome

Am J Med

(1985)

BrewB.J. et al.

Human immunodeficiency vines type 1-related transient neurological deficits

Am J Med

(1996)

PlotzP.

Autoantibodies are anti-idiotype antibodies to antiviral antibodies

Lancet

(1983)

GuilbertB. et al.

Naturally occuring antibodies against nine common antigens in human sera

J Immunol

(1982)

SchattnerA. et al.

Virus-induced autoimmunity

Rev Inf Dis

(1990)

SuttonR.N.P. et al.

The occurrence of autoantibodies in infectious mononucleosis

Clin Exp Immunol

(1974)

TohB.I.T. et al.

Viral infections and IgM autoantibodies to cytoplasmic intermediate filaments

Clin Exp Immunol

(1979)

NiwaY. et al.

Transient autoantibodies with elevated complement levels in common viral diseases

J Clin Lab Immunol

(1984)

Cited by (85)

Autoimmunity and HIV infection
2022, Translational Autoimmunity: Autoimmune Disease Associated with Different Clinical Features
HIV infection is the most common etiology of secondary immunodeficiency worldwide. The improvement in HIV therapeutics has transformed a devastating condition to a manageable chronic disease. The main health issues in people with HIV in the current era are conditions related to the aging process. In common with other immunodeficiency states, there is an imbalance of the immune system that can favor the development of autoimmune diseases. Like any infectious agent, HIV can trigger autoimmunity by mechanisms such as epitope spreading or bystander activation. However, HIV infection also generates a sustained state of immune activation and early immunosenescence of the immune system. Autoimmunity may be present in every stage of the natural history of HIV infection. This chapter will review the interplay between HIV infection and the immune system, the mechanisms it can generate autoimmunity, and an overview of the primary autoimmune diseases commonly diagnosed in patients with HIV infection.
Prescription medication use and antinuclear antibodies in the United States, 1999–2004
2018, Journal of Autoimmunity
Citation Excerpt :
In the general US population, ANA are more common in women, older individuals, African Americans, and persons of normal weight [3]. They are also associated with childbearing [4]; certain genes [5]; and environmental agents, such as chemicals, occupational exposures, infections, and medications [6–10]. The present study focuses on prescription medications, some of which have been reported to induce ANA and symptoms of lupus or other autoimmune diseases in specific individuals.
Clinical reports link specific medications with the development of antinuclear antibodies (ANA), but population-based evidence is limited.
The present study investigated associations between prescription medication use and ANA in a representative sample of the adult noninstitutionalized US population, first focusing on medications previously related to ANA and then considering all medications reported in the National Health and Nutrition Examination Survey (NHANES).
Based on NHANES data (1999–2004) for 3608 adults (ages ≥18 years), we estimated odds ratios (ORs) and 95% confidence intervals (CIs) to assess associations between recent medication use and ANA (overall and in sex and age subgroups), adjusted for potential confounders and the survey sampling design.
We found no evidence that most medications previously associated with ANA in specific individuals were risk factors for ANA in the general population, although statistical power was limited for some medications. Overall, ANA were less prevalent in adults who recently used any prescription medications compared with those who did not (OR = 0.73; CI = 0.57,0.93), and likewise several classes of medications were inversely associated with ANA, including hormones (OR = 0.73; CI = 0.55,0.98), thiazide diuretics (OR = 0.43; CI = 0.24,0.79), sulfonylureas (OR = 0.41; CI = 0.19,0.89), and selective serotonin reuptake inhibitor antidepressants (OR = 0.65; CI = 0.42,0.98). Positive associations with ANA were seen for loop diuretics (OR = 1.72; CI = 1.03,2.88) in all adults, and for benzodiazepines (OR = 2.11; CI = 1.09,4.10) and bronchodilators (OR = 1.83; CI = 1.00,3.38) in older (ages ≥60) adults. Estrogens were positively associated with ANA in older women (OR = 1.80; CI = 1.00,3.23) but inversely associated with ANA in younger (ages 18–59) women (OR = 0.43; CI = 0.20,0.93). Regarding individual medications, ANA were positively associated with ciprofloxacin (OR = 4.23; CI = 1.21,14.8), furosemide (OR = 1.79; CI = 1.09,2.93), and omeprazole (OR = 2.05; CI = 1.03,4.10) in all adults, and with salmeterol (OR = 3.76; CI = 1.66,8.52), tolterodine (OR = 6.64; CI = 1.45,30.5), and triamterene (OR = 3.10; CI = 1.08,8.88) in older adults. Also, in younger adults, hydrochlorothiazide was inversely associated with ANA (OR = 0.44; CI = 0.20,0.98).
Our findings in the general population do not confirm most clinically reported positive associations between specific medications and ANA in some individuals. However, novel positive ANA associations with other medications, as well as unexplained inverse associations with certain classes of medications and overall medication use, deserve further research to clarify the possible roles of medications as risk and protective factors in the development of autoantibodies and autoimmune disease.
Infections of Joints, Synovium-Lined Structures, and Soft Tissue
2018, Diagnostic Pathology of Infectious Disease
Viral Hepatitis
2018, MacSween's Pathology of the Liver
The quest for autoreactive antibodies in nasal polyps
2016, Journal of Allergy and Clinical Immunology
Distinct subsets of anti-pulmonary autoantibodies correlate with disease severity and survival in severe COVID-19 patients
2024, GeroScience

View all citing articles on Scopus

View full text

Autoantibodies and common viral illnesses

Abstract

Objectives:

Methods:

Results:

Conclusions:

Immunol Lett

Clin Immunol Immunopathol

Lancet

Am J Med

Blood

Lancet

J Infect

Hepatology

Semin Arthritis Rheum

Hepatology

J Hepatol

Am J Med

Am J Med

Lancet

Naturally occuring antibodies against nine common antigens in human sera

J Immunol

Virus-induced autoimmunity

Rev Inf Dis

The occurrence of autoantibodies in infectious mononucleosis

Clin Exp Immunol

Viral infections and IgM autoantibodies to cytoplasmic intermediate filaments

Clin Exp Immunol

Transient autoantibodies with elevated complement levels in common viral diseases

J Clin Lab Immunol